Manipulating the PD-1 pathway to improve immunity, Current Opinion in Immunology, vol.25, issue.3, pp.381-389, 2013. ,
DOI : 10.1016/j.coi.2013.03.003
PD-1 signaling in primary T cells, Immunological Reviews, vol.5, issue.1, pp.114-139, 2009. ,
DOI : 10.1111/j.1600-065X.2009.00767.x
Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor, Immunity, vol.11, issue.2, pp.141-51, 1999. ,
DOI : 10.1016/S1074-7613(00)80089-8
PD-1 and Its Ligands in Tolerance and Immunity, Annual Review of Immunology, vol.26, issue.1, pp.677-704, 2008. ,
DOI : 10.1146/annurev.immunol.26.021607.090331
PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3?? signalosome and downstream signaling to PKC??, FEBS Letters, vol.4, issue.1-3, pp.37-41, 2004. ,
DOI : 10.1016/j.febslet.2004.07.083
Tumorassociated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion, Nat Med, vol.8, pp.793-800, 2002. ,
Targeting PD-1/PD-L1 interactions for cancer immunotherapy, OncoImmunology, vol.8, issue.8 ,
DOI : 10.1016/j.coi.2011.12.009
Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired, Blood, vol.114, issue.8, pp.1537-1581, 2009. ,
DOI : 10.1182/blood-2008-12-195792
PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors, Journal of Clinical Investigation, vol.124, issue.5, pp.2246-59, 2014. ,
DOI : 10.1172/JCI73639DS1
Safety and Tumor Responses with Lambrolizumab (Anti???PD-1) in Melanoma, New England Journal of Medicine, vol.369, issue.2, pp.134-178, 2013. ,
DOI : 10.1056/NEJMoa1305133
Association of PD-1, p.1 ,
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer, Science, vol.348, issue.6230, pp.124-132, 2015. ,
DOI : 10.1126/science.aaa1348
A Full GMP Process to Select and Amplify Epitope-Specific T Lymphocytes for Adoptive Immunotherapy of Metastatic Melanoma, Clinical and Developmental Immunology, vol.164, issue.2, p.932318, 2013. ,
DOI : 10.1097/00008390-200209000-00011
Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor., Proceedings of the National Academy of Sciences, vol.91, issue.9, pp.3515-3524, 1994. ,
DOI : 10.1073/pnas.91.9.3515
MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency, The Journal of Experimental Medicine, vol.6, issue.11, pp.2673-82, 2008. ,
DOI : 10.1038/76292
Cutting Edge: Prolonged Exposure to HIV Reinforces a Poised Epigenetic Program for PD-1 Expression in Virus-Specific CD8 T Cells, The Journal of Immunology, vol.191, issue.2, pp.540-544, 2013. ,
DOI : 10.4049/jimmunol.1203161
Chronic Virus Infection Enforces Demethylation of the Locus that Encodes PD-1 in Antigen-Specific CD8+ T Cells, Immunity, vol.35, issue.3, pp.400-412, 2011. ,
DOI : 10.1016/j.immuni.2011.06.015
A fast and efficient HLA multimer-based sorting procedure that induces little apoptosis to isolate clinical grade human tumor specific T lymphocytes, Cancer Immunology, Immunotherapy, vol.320, issue.4, pp.553-66, 2009. ,
DOI : 10.1007/s00262-008-0578-2
The Transcription Factor NFAT Promotes Exhaustion of Activated CD8 T Cells NFATc1 regulates PD-1 expression upon T cell activation, Immunity J Immunol, vol.27, issue.181, pp.4832-4841, 2008. ,
Genetic absence of PD-1 ,
Absence of Programmed Death Receptor 1 Alters Thymic Development and Enhances Generation of CD4/CD8 Double-Negative TCR-Transgenic T Cells, The Journal of Immunology, vol.171, issue.9, pp.4574-81, 2003. ,
DOI : 10.4049/jimmunol.171.9.4574
Facilitation of ?? Selection and Modification of Positive Selection in the Thymus of Pd-1???Deficient Mice, The Journal of Experimental Medicine, vol.10, issue.5, pp.891-899, 2000. ,
DOI : 10.1016/S1074-7613(00)80502-6
Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs, International Immunology, vol.19, issue.10, pp.1223-1257, 2007. ,
DOI : 10.1093/intimm/dxm091
France) (C) IFN-? production of PD-1 neg and PD-1 pos T cell clones in response to melanoma cell lines. IFN-? production was measured by ELISA (n=2) in supernatants of PD-1 neg (left column, dotted lines) and PD-1 pos (right column, solid lines) T cell clones after 6h of activation with M113 melanoma cell line (white circles) or, 2015. ,